Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Balance Sheets (Unaudited)

v3.25.3
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Sep. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 305.5 $ 415.3
Receivables, net of allowance for doubtful accounts 97.8 68.9
Inventories 512.5 475.4
Prepaid expenses and other current assets 190.4 184.1
Total current assets 1,106.2 1,143.7
Property, plant, and equipment, at cost, net of accumulated depreciation and amortization 456.7 460.2
Operating lease right-of-use assets 171.7 185.7
Marketing-related intangibles and other intangible assets, net 315.7 312.3
Goodwill 101.0 87.7
Deferred income tax assets 401.7 398.6
Other assets 144.2 139.9
Total assets 2,697.2 2,728.1
Current liabilities:    
Accounts payable 88.1 70.0
Royalty overrides 345.8 334.1
Current portion of long-term debt 20.7 283.5
Other current liabilities 545.3 542.8
Total current liabilities 999.9 1,230.4
Long-term debt, net of current portion 1,997.2 1,976.6
Non-current operating lease liabilities 157.0 169.5
Other non-current liabilities 149.1 152.7
Total liabilities 3,303.2 3,529.2
Commitments and contingencies
Shareholders' deficit:    
Common shares, $0.0005 par value; 2.0 billion shares authorized; 103.2 million (2025) and 101.2 million (2024) shares outstanding 0.1 0.1
Paid-in capital in excess of par value 304.6 278.2
Accumulated other comprehensive loss (251.6) (271.4)
Accumulated deficit (665.1) (808.0)
Total Herbalife shareholders' deficit (612.0) (801.1)
Noncontrolling interest 6.0 0.0
Total shareholders' deficit (606.0) (801.1)
Total liabilities and shareholders' deficit $ 2,697.2 $ 2,728.1